Polycythemia Vera News and Research

RSS
Johns Hopkins scientists use genome editing technology to alter human stem cells

Johns Hopkins scientists use genome editing technology to alter human stem cells

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

NeoGenomics launches new test for detection of mutations in CALR gene

NeoGenomics launches new test for detection of mutations in CALR gene

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

AMP 2013: EKF Molecular Diagnostics to launch four new PointMan DNA enrichment kits

AMP 2013: EKF Molecular Diagnostics to launch four new PointMan DNA enrichment kits

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Two studies shed light on molecular biology of three blood disorders

Two studies shed light on molecular biology of three blood disorders

Researchers find white blood cells produce and eliminate RBCs

Researchers find white blood cells produce and eliminate RBCs

Studies examine current treatment standards for patients with clotting disorders

Studies examine current treatment standards for patients with clotting disorders

Tool reveals myeloproliferative neoplasm patient burden

Tool reveals myeloproliferative neoplasm patient burden

Novartis receives EC approval for Jakavi to treat myelofibrosis

Novartis receives EC approval for Jakavi to treat myelofibrosis

Researchers uncover protein structure that regulates blood cell formation and activity

Researchers uncover protein structure that regulates blood cell formation and activity

New details about how cell signalling is controlled in immune system

New details about how cell signalling is controlled in immune system